Navigation Links
CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities
Date:9/29/2008

SARASOTA, Fla., Sept. 29 /PRNewswire-FirstCall/ -- CPC of America, Inc. (OTC Bulletin Board: CPCF.OB) today announced that it had retained FTI Capital Advisors, LLC, the investment banking subsidiary of FTI Consulting, Inc., to explore strategic alternatives for the Company.

As CPC of America's financial advisor, FTI Capital Advisors will report to the Board any expressions of interest from third parties seeking to pursue a possible licensing agreement or acquisition of the Company or its technology. CPC of America has authorized FTI Capital Advisors to contact parties and to report back so that the Board can evaluate any expressions of interest and determine whether a transaction would be in the best interests of shareholders. There can be no assurance that this process will result in any expressions of interest or a transaction, and the Company does not currently intend to publicly disclose further information regarding the status of its review until the process has been completed.

CPC of America also announced today that it has appointed FTI's Strategic Communications practice, FD, to provide public and investor relations counsel to the Company. One of the world's most sought-after business and financial communications consultancies, FD helps many of the world's leading organizations harness the power of communications to capitalize upon business opportunities. FD's Life Sciences group advises pharmaceutical and medical device entities ranging from global leaders to emerging, development-stage companies.

CPC of America's Chairman and CEO Rod A. Shipman notes, "CPC expects to benefit greatly from the counsel and support of FTI's consulting services in seeking to explore strategic alternatives and raise the visibility of our technology. We look forward to working with our advisors to examine and implement ways to maximize shareholder value."

About CPC

CPC of America acquires, develops and oversees the manufacturing of cardiology therapeutic devices for the diagnosis and treatment of coronary artery disease. CPC's current focus is the completion of development and testing of MedClose(TM) Vascular Closure System, an internal puncture-closing device for use in catheter laboratories. The Company is currently seeking FDA approval for MedClose(TM).

About FTI Consulting

FTI Capital Advisors and FD are part of the FTI Consulting, Inc. (NYSE: FCN) company group. FTI is a global business advisory firm dedicated to helping organizations protect and enhance enterprise value in an increasingly complex legal, regulatory and economic environment. With more than 3,000 employees located in most major business centers in the world, FTI works closely with clients every day to anticipate, illuminate, and overcome complex business challenges in areas such as investigations, litigation, mergers and acquisitions, regulatory issues, reputation management and restructuring.

FTI Capital Advisors, LLC (FINRA/SIPC) is the investment banking arm of FTI Consulting, Inc. FTI Capital Advisors leverages off the global footprint of its parent to provide its clients with access to buyers, sellers, investors and lenders worldwide.

A market leader in M&A advisory work, FD's services include financial public relations, capital markets communications, public affairs, crisis and issues management and corporate, business-to-business and business-to-consumer communications. FD is structured around specialist sector teams operating on an international basis, covering consumer industries, financial services, basic industries, business services, life sciences & healthcare, media, real estate, technology and telecommunications.


'/>"/>
SOURCE CPC of America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nano-Bio-Info-Cogno Revolutions to be Explored at Convergence08 Unconference - Forecaster Paul Saffo to Keynote
2. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
3. Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data
4. Verenium Explores Bacterial Genes Inside Termite Guts to Understand How Wood is Broken Down and Converted to Energy
5. Aktiv-Dry Awarded Research Grant to Explore Inhalable siRNA Dry Powder Targeting RSV
6. Global Experts Explore Entire Spectrum of Aids Vaccine Development
7. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
8. TorreyPines Therapeutics Strategically Repositions as Development Company Focusing on Three Versatile Lead Compounds
9. Alfacell Hires Advisors to Advance Strategic Alternatives
10. MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process
11. GlaxoSmithKline and Cellzome Announce Major Strategic Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
(Date:10/9/2017)... FL (PRWEB) , ... October 09, 2017 , ... The ... scheduled to broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. ... industry is faced with the challenge of how to continue to feed a growing ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... instruments and applications consulting for microscopy and surface analysis, Nanoscience Instruments is ... Nanoscience Analytical offers a broad range of contract analysis services for advanced ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
Breaking Biology News(10 mins):